BioMS GmbH. has developed a point of care (POC) platform technology-based on molecular diagnostic technology with applications in gynecology, infectious diseases, oncology, veterinary, and other applications.
CE certified Venus GTest™ is the first revolutionary application in the gynecology field. It detects the three most common vaginal infections; BacterialVaginosis, Trichomoniasis, and Candidiasis in ~ 1 minute. It is simple to use, accurate and measures simultaneously the fingerprint signature of the three vaginal infections from a single swab.
On January 22, 2013, 1st International Scientific Seminar" was held in Sheba Medical Center, Israel, with the participation of global key opinion leaders (KOL's) from the gynecological field including representatives from USA Detroit, Turkey Ankara and Israel Tel-Aviv. The Seminar discussed the latest news and updates in vaginitis, especially Bacterial Vaginosis which is considered the most common form of vaginal infections. Zeev Karpas PhD., from NRC/ATMBD explained the essentials of Innovation's platform technology and the features that make it accurate. Prof. Jack Sobel gave a comprehensive presentation about vaginitis diseases and the difficulties that gynecologists are facing to detect them. Prof. Michael Dan USA & from Tel Aviv University, spoke about Vulvovaginal Candidiasis and the problem of reoccurrence due to lack of accurate diagnostic tools.
It was discussed amongst the group that the current tools (e.g. microscopy, culture, etc) are believed to be either under-diagnose or over-diagnose the infections. The technology presented its current product "The VENUE GT™" and discussed how it would provide the ideal solution for diagnosing vaginitis in a quick, sensitive and easy to use format and address the challenges raised by the panel.
Research and News Update
For Infectious in Obstetrics and Gynecology
Oct.26th - 29th, 2017